These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 30599875)

  • 1. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
    Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
    Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Zeng P; Ma L; Liu J; Song Z; Liu J; Yuan H
    Eur J Radiol; 2022 May; 150():110261. PubMed ID: 35316674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
    Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
    AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhypovascular pancreatic ductal adenocarcinomas: CEUS imaging findings and differentiation from other types of solid pancreatic lesions.
    Wang L; Nie F; Dong T; Yin C; Li M; Li Y
    Clin Hemorheol Microcirc; 2022; 81(2):163-176. PubMed ID: 35253738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
    Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
    Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Diagnosis of Nonhypervascular Pancreatic Neuroendocrine Neoplasms From Pancreatic Ductal Adenocarcinomas, Based on Computed Tomography Radiological Features and Texture Analysis.
    Yu H; Huang Z; Li M; Wei Y; Zhang L; Yang C; Zhang Y; Song B
    Acad Radiol; 2020 Mar; 27(3):332-341. PubMed ID: 31495760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
    Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A
    Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology.
    Zamboni GA; Ambrosetti MC; Zivelonghi C; Lombardo F; Butturini G; Cingarlini S; Capelli P; Pozzi Mucelli R
    HPB (Oxford); 2017 Nov; 19(11):986-991. PubMed ID: 28784262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
    Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
    Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.
    Kim JH; Eun HW; Kim YJ; Lee JM; Han JK; Choi BI
    Eur Radiol; 2016 May; 26(5):1338-47. PubMed ID: 26253257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can MDCT or EUS features predict the histopathological grading scheme of pancreatic neuroendocrine neoplasms?
    Zhu H; Ying L; Tang W; Yang X; Sun B
    Radiol Med; 2017 May; 122(5):319-326. PubMed ID: 28176217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
    Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
    Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography.
    Kitano M; Kudo M; Yamao K; Takagi T; Sakamoto H; Komaki T; Kamata K; Imai H; Chiba Y; Okada M; Murakami T; Takeyama Y
    Am J Gastroenterol; 2012 Feb; 107(2):303-10. PubMed ID: 22008892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by the "Duct-Road Sign": A preliminary magnetic resonance imaging study.
    Xiao B; Jiang ZQ; Hu JX; Zhang XM; Xu HB
    Medicine (Baltimore); 2019 Aug; 98(35):e16960. PubMed ID: 31464937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.